In the Matter of SHINE Technologies, LLC; SHINE Medical Isotope Production Facility; Direct and Indirect Transfers of License
Nuclear Regulatory Commission
Questions this answers
Sources
- Federal Register · checked 2026-04-30
Source record
The underlying regulation record — supporting evidence for the object above.
Key Details
- Posted Date
- NAICS Code
- 236220
- Source
- Federal Register
Description
The U.S. Nuclear Regulatory Commission (NRC) is issuing an order approving the license transfer application filed by SHINE Technologies, LLC, dated February 4, 2026, as supplemented on April 13, 2026. Specifically, the order approves the direct transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility from SHINE Technologies, LLC to SHINE Chrysalis, LLC and a conforming license amendment. The order also approves the indirect transfer of control of the construction permit as a result of the establishment of SHINE Chrysalis Holdings, LLC as the direct parent company of SHINE Chrysalis, LLC. SHINE Chrysalis Holdings, LLC is a wholly owned subsidiary of Illuminated Holdings, Inc., the current parent company of SHINE Technologies, LLC.
Frequently Asked Questions
Does this regulation apply to me?+
Where this record sits
What to ask next
- What else has Nuclear Regulatory Commission published?
- New this week at Nuclear Regulatory Commission
- What regulation activity is in Commercial and Institutional Building Construction (NAICS 236220)?
- What regulation activity is in NONRESIDENTIAL BUILDING CONSTRUCTION (NAICS 2362)?
- What regulation activity is in CONSTRUCTION (NAICS 23)?
- Browse this record family